哪些患者静脉血栓栓塞症复发风险高?
综述探讨静脉血栓栓塞症(VTE)复发风险评估,指出一过性重大危险因素(如全身麻醉>30分钟手术)相关VTE复发风险低,推荐限时抗凝;无诱因或持续危险因素者复发风险高。文章回顾不同临床情况下的复发风险,包括性别特异性风险(激素和妊娠相关VTE),并讨论复发与出血的竞争影响如何塑造国际指南推荐。
要点
- 一过性重大危险因素相关VTE复发风险低,推荐限时抗凝。
- 无诱因或持续危险因素VTE患者复发风险较高。
- 评估复发风险需考虑性别及激素/妊娠相关因素。
核心结论
- VTE复发风险评估应基于初始事件的诱发情况,一过性重大危险因素者复发风险低,无诱因或持续危险因素者复发风险高。
研究设计与样本
- 综述文献,探讨不同临床条件下VTE复发风险,包括性别特异性风险及指南推荐形成依据。
主要发现
- 一过性重大危险因素(如全身麻醉>30分钟手术)相关VTE,停止抗凝后预测复发风险低。
- 无诱因或持续危险因素VTE患者复发风险较高。
- 性别特异性风险包括激素和妊娠相关VTE事件的复发风险。
关键数值与推荐
- 一过性重大危险因素:手术 associated with general anesthesia for >30 minutes。
- 推荐:一过性重大危险因素相关VTE,一般推荐限时抗凝。
临床怎么用
- 评估VTE复发风险需结合初始事件的诱发因素,区分一过性重大危险因素、持续危险因素和无诱因。
- 对一过性重大危险因素相关VTE考虑限时抗凝,对无诱因或持续危险因素者需评估长期抗凝。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent venous thromboembolism (VTE, or deep vein thrombosis and pulmonary embolism) is associated with mortality and long-term morbidity. The circumstances in which an index VTE event occurred are crucial when personalized VTE recurrence risk is assessed. Patients who experience a VTE event in the setting of a transient major risk factor (such as surgery associated with general anesthesia for >30 minutes) are predicted to have a low VTE recurrence risk following discontinuation of anticoagulation, and limited-duration anticoagulation is generally recommended. In contrast, those patients whose VTE event occurred in the absence of risk factors or who have persistent risk factors have a higher VTE recurrence risk. Here, we review the literature surrounding VTE recurrence risk in a range of clinical conditions. We describe gender-specific risks, including VTE recurrence risk following hormone- and pregnancy-associated VTE events. Finally, we discuss how the competing impacts of VTE recurrence and bleeding have shaped international guideline recommendations.
引用
- Áinle FN, Kevane B. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? Blood Adv. 2020. PMID: 33170937. doi:10.1182/bloodadvances.2020002268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。